跳至主要内容
临床试验/JPRN-UMIN000010258
JPRN-UMIN000010258已完成未知

Phase II study evaluating efficacy and safety of peripheral blood stem cell harvest with bortezomib for multiple myeloma - SMUIM4-MM02

Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine0 个研究点目标入组 30 人开始时间: 2013年3月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 65years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1) Patients HIV-HBs-and HCV-positive. 2) Severe hepatic dysfunction, severe renal failure, severe cardiac dysfunction, severe pulmonary dysfunction, uncontrolled diabetes, uncontrolled hypertension, and uncontrolled infection. 3) Patients with a history of active malignancy. 4) Patients with severe psychiatric disorders. 5) Patients with pregnancy or lactation. 6) Those who are considered as inappropriate to register by attending physicians.

研究者

发起方
Fourth Department of Internal Medicine, Sapporo Medical University, School of Medicine

相似试验